Biotech VCs See Room for More Growth in Obesity Drug Market
The Wall St. Journal
Antibiotic Resistance is a Looming Crisis. CRISPR May Hold the Answer
WIRED
BioAge raises $170M as obesity spotlight shifts to oral options, muscle preservers
Endpoints News
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics
Thermal
The Age of CRISPR: Engineering the Future of Genetic Medicine
TED
Innovative Genomics Institute and Danaher Join Forces to Accelerate and Scale Up the Development of CRISPR Cures
Thermal
Gene Editing Needs to Be for Everyone
WIRED
The Most Secretive Longevity Lab Finally Opens Its Doors
Bloomberg BusinessWeek
The First Crispr Therapy Is Just the Start of the Gene-Editing Revolution
Bloomberg News
FDA approves first gene-editing treatment for human illness
NPR
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
The New York Times
FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease
The Wall St. Journal
FDA approves two sickle cell therapies, including first CRISPR medicine
The Washington Post
FDA Approves First CRISPR Treatment in U.S.
TIME
The CRISPR Era Is Here
The Atlantic
Gene Editing Will Change Medicine—and Maybe Health Investing Too
The Wall St. Journal
Key questions (and answers) about the historic approval of a CRISPR-based medicine
STAT News
The Hard Problems issue
MIT Technology Review
The FDA Must Decide Whether Crispr’s Gene-Editing Promise Is Worth the Risk
Bloomberg BusinessWeek
FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease
NPR
Crispr Pioneer Jennifer Doudna Has the Guts to Take On the Microbiome
WIRED
age1 Launches to Advance The Longevity Fund’s Mission to Extend Healthy Lifespan
Thermal
Former Google AI expert raises $100mn for biotech start-up
Financial Times
Former Google AI leader lands $100M Series A raise for ‘biological software’ startup
Endpoints News
Want to live healthier longer? Visual guide shows how longevity science looks to slow diseases of aging
USA Today
How We Age—and How Scientists Are Working to Turn Back the Clock
The Wall St. Journal
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Forbes
Curing Cancers, Extending Life, and Other Medical Moonshots
The Atlantic
How gene-edited microbiomes could improve our health
MIT Technology Review
Concert Health Announces Results of Collaborative Care Partnership with Mercy Health
Thermal
A.I. May Someday Work Medical Miracles. For Now, It Helps Do Paperwork.
The New York Times
Suddenly, It Looks Like We’re in a Golden Age for Medicine
The New York Times
A 988 operator, faced with a flood of calls, turns to AI to boost counselor skills
STAT News
Scribe Inks CRISPR Gene-Editing Deal with Prevail
Bloomberg Technology
Lilly’s Prevail taps Jennifer Doudna’s spinout Scribe Therapeutics for neuro genetic medicines
Endpoints News
Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases
Thermal
The most influential people in biopharma in 2023
Fierce Pharma
A new era for treating sickle cell disease could spark a health-care revolution
The Washington Post
Jennifer Doudna’s research institute takes CRISPR to cow burps in quest to solve climate change
Fierce Biotech
How AI experts are using GPT-4
MIT Technology Review
Sam Altman invested $180 million into a company trying to delay death
MIT Technology Review
A longevity expert who studied people who live to 110 on how humanity and AI will master aging
CNBC
Ambience Healthcare Aims To Reduce Clinician Burnout With New AI Medical Scribe
MedCity News
The Cure(ious)
NYSE
No more ‘playing God’: How the longevity field is trying to recast its work as serious science
STAT News
The start-ups seeking a cure for old age
Financial Times
Can aging be cured? Scientists are giving it a try
National Geographic
We Can Cure Disease by Editing a Person’s DNA. Why Aren’t We?
The New York Times
Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement
Thermal
BioAge Announces Positive Topline Results for BGE-105 in Phase 1b Clinical Trial Evaluating Muscle Atrophy in Older Volunteers at Bed Rest
Thermal
Asteroids! Solar Storms! Nukes! Climate Calamity! Killer Robots!
The Washington Post
CRISPR’s Second Decade: Jennifer Doudna Looks Forward and Back
Genetic Engineering and Biotechnology News
Brightseed Introduces Bio 01™, the First Dietary Fiber with Bioactives to Support Gut Strength
Thermal
How scientists want to make you young again
MIT Technology Review
The Future Perfect 50
Vox
‘Food-as-Medicine’ Startups Draw Venture Capital
The Wall St. Journal
Sanofi pays Scribe $25M to access CRISPR tools, writing new chapter in its NK cell therapy story
Fierce Biotech
Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer
Thermal
Starting a Revolution Isn’t Enough
The Atlantic